Biosimilars Market Research Reports & Industry Analysis
The worldwide prescription generic drug market has stood the test of time and has endured numerous growing pains. However, it has evolved into a formidable and important participant in the complex world of health care. Generic drugs continue to represent one of the greatest values in healthcare and are of great importance in the area of biopharmaceuticals as well because these products are among the most expensive treatments currently on the market.
Generic drug manufacturers are poised for strong growth in the future because the patent protection for a host of major biopharmaceuticals will expire and new legislative reforms in the generic drug approval process may facilitate bringing products to market. While there are many issues to address, the outlook for the promotion of biosimilars is favorable in the next five years.
Biosimilars Industry Research & Market Reports
-
2023 Global Biosimilar Contract Manufacturing Industry (2029 Outlook)
... Market Outlook reports provide market size data for a three-year historical trend (2017-2020), a three-year forecast estimate trends (2021-2023), and a five-year outlook projection (2024-2029) for 46 countries. Market and product shipments include the total ... Read More
-
2023 Global Biosimilar Monoclonal Antibodies Market Industry (2029 Outlook)
... Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2017-2020), a three-year forecast estimate trends (2021-2023), and a five-year outlook projection (2024-2029) for 46 countries. Market and product shipments include ... Read More
-
Global Biosimilars Market - 2023-2030
... is expected to exhibit a CAGR of 12.8% during the forecast period 2023-2030. Biosimilars provide an opportunity to increase patient access to biological therapies by offering more affordable alternatives while maintaining the same therapeutic benefits. ... Read More
-
2023 Global Forecast for Oncology Biosimilars Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Erythropoietin Drugs Market Share, Size, Trends, Industry Analysis Report, By Type (Biologics & Biosimilars); By Product (Erythropoietin, Darbepoetin-alfa); By Application; By Region; Segment Forecast, 2023 - 2032
... to reach USD 7.65 billion by 2032, according to a new study by Polaris Market Research. The report “Erythropoietin Drugs Market Share, Size, Trends, Industry Analysis Report, By Type (Biologics & Biosimilars); By Product (Erythropoietin, ... Read More
-
Impact of Inflation on the Healthcare Sector by Physicians Perspective, Patient Treatment, Regional Analysis, Drug Prices and Treatment Costs - Thematic Intelligence
... continues to examine the impact of inflation on healthcare systems, patients, and HCPs. The report provides an overview of the current and future outlook of the healthcare sector, government policies, innovative technologies, and initiatives that ... Read More
-
Biosimilars Market by Drug Class (Drug Class (Monoclonal Antibodies (Adalimumab, Infliximab, Rituximab, Trastuzumab), Insulin, Erythropoietin, Anticoagulants. rhGH), Indication, Region – Global Forecast to 2028
... billion by 2028 from USD 29.4 billion in 2023, at a CAGR of 17.8% during the forecast period. Factors such as regulatory approvals, favorable reimbursement policies, rising demand for cost effective biosimilars is driving the ... Read More
-
Global Lucentis (Ranibizumab) and Biosimilar Market Growth 2023-2029
... to grow at a CAGR of -2.7% from 2023 to 2029. United States market for Lucentis (Ranibizumab) and Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a ... Read More
-
Global Humira Biosimilar Market Growth 2023-2029
... CAGR of 13.0% from 2023 to 2029. The introduction of Humira biosimilars is expected to increase competition in the market, leading to lower prices and improved access to treatment for patients. The availability of biosimilars ... Read More
-
Global Herceptin (Trastuzumab) and Biosimilar Market Growth 2023-2029
... to grow at a CAGR of 5.0% from 2023 to 2029. United States market for Herceptin (Trastuzumab) and Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a ... Read More
-
Global Bevacizumab Monoclonal Antibody Biosimilar Market Growth 2023-2029
... to grow at a CAGR of -15.0% from 2023 to 2029. United States market for Bevacizumab Monoclonal Antibody Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a ... Read More
-
Global Epogen and Biosimilar Market Growth 2023-2029
... at a CAGR of -3.3% from 2023 to 2029. United States market for Epogen and Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % ... Read More
-
Global Neulasta (Pegfilgrastim) and Biosimilar Market Growth 2023-2029
... to grow at a CAGR of 6.7% from 2023 to 2029. United States market for Neulasta (Pegfilgrastim) and Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a ... Read More
-
Global Adalimumab (Humira) and Biosimilar Market Growth 2023-2029
... to grow at a CAGR of -5.3% from 2023 to 2029. The expiration of patents for adalimumab (Humira) has emerged as a significant driver in the biosimilar market. Adalimumab is a widely used biologic medication ... Read More
-
Global Thyrogen and Biosimilar Market Growth 2023-2029
... at a CAGR of 16.3% from 2023 to 2029. United States market for Thyrogen and Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % ... Read More
-
Global Avastin Biosimilar Market Growth 2023-2029
... CAGR of -15.0% from 2023 to 2029. United States market for Avastin Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through ... Read More
-
Global Enbrel (Etanercept) and Biosimilar Market Growth 2023-2029
... to grow at a CAGR of 3.4% from 2023 to 2029. United States market for Enbrel (Etanercept) and Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a ... Read More
-
Global Remicade (Infliximab) and Biosimilar Market Growth 2023-2029
... to grow at a CAGR of 5.8% from 2023 to 2029. United States market for Remicade (Infliximab) and Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a ... Read More
-
Global Rituxan (Rituximab) and Biosimilar Market Growth 2023-2029
... to grow at a CAGR of 3.6% from 2023 to 2029. United States market for Rituxan (Rituximab) and Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a ... Read More
-
Global Enbrel (Etanercept) Biosimilar Market Growth 2023-2029
... at a CAGR of 4.8% from 2023 to 2029. United States market for Enbrel (Etanercept) Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % ... Read More
-
Global Adalimumab Monoclonal Antibody Biosimilar Market Growth 2023-2029
... to grow at a CAGR of 13.0% from 2023 to 2029. The introduction of Humira biosimilars is expected to increase competition in the market, leading to lower prices and improved access to treatment for patients. ... Read More
-
Biosimilar Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... a number of factors such as patent expires of blockbuster biological drugs, lower prices, rising prevalence of chronic diseases, and cost-saving initiatives from governments and third-party payers. Catalyzed by these factors, the market is expected ... Read More
-
Active Pharmaceutical Ingredients (API) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... market to reach US$ 303.9 Billion by 2028, exhibiting a growth rate (CAGR) of 5.6% during 2023-2028. Active pharmaceutical ingredient (API), is the term that is used to refer to the biologically active component of ... Read More
-
Global Biobetters Market - 2023-2030
... global biobetters market is exhibiting at a CAGR of 8.5% during the forecast period (2023-2030). The market trends of biobetters are PEGylation fusion proteins, EKylation, XTEN technology, Pasylation, and so on. Fusion proteins are created ... Read More
-
Biosimilar Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type
... CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028. For geography segment, regional supply, demand, major players, price is presented from ... Read More